A detailed history of Mid Atlantic Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mid Atlantic Capital Management, Inc. holds 34 shares of LLY stock, worth $27,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34
Holding current value
$27,000
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $26,252 - $32,640
34 New
34 $30.1 Million
Q1 2024

Nov 12, 2024

SELL
$592.2 - $792.28 $6,514 - $8,715
-11 Reduced 32.35%
23 $17.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mid Atlantic Capital Management, Inc. Portfolio

Follow Mid Atlantic Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid Atlantic Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid Atlantic Capital Management, Inc. with notifications on news.